Lupus Trial, Recruiting (NCT07043153)

Lupus Trial, Recruiting NCT07043153 Sponsor: Sohag University Condition: Lupus

Printed from Voxsanity (voxsanity.com.au) — NCT07043153 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Lupus

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You must be 18 years old or older.
Both men and women can take part.
You must have been diagnosed with Systemic Lupus Erythematosus (SLE, also known as lupus), confirmed using a specific set of internationally recognised medical guidelines called the SLICC criteria, or you may be eligible as a healthy comparison participant (confirm with trial site).

Who may not be able to join:

You have another long-term inflammatory or immune system condition alongside lupus.
You are under 18 years of age.
You have been diagnosed with cancer of any kind.
You are currently pregnant or breastfeeding.
You have long-term liver or kidney problems that affect how these organs work.
You have a serious blood-related cancer or blood disorder.
You currently have an active hepatitis infection (a liver infection caused by a hepatitis virus).
You have had an active infection of any kind in the four weeks before joining the trial.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 27 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Esam M Abualfadl, Professor, Sohag University

Phone: 20 01122385665

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07043153

Sponsor: Sohag University

Phase: Not Applicable

Status: Recruiting

Condition: Lupus

Trial contact: 20 01122385665

More information: https://clinicaltrials.gov/study/NCT07043153

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You must be 18 years old or older.
Both men and women can take part.
You must have been diagnosed with Systemic Lupus Erythematosus (SLE, also known as lupus), confirmed using a specific set of internationally recognised medical guidelines called the SLICC criteria, or you may be eligible as a healthy comparison participant (confirm with trial site).

Who may not be able to join:

You have another long-term inflammatory or immune system condition alongside lupus.
You are under 18 years of age.
You have been diagnosed with cancer of any kind.
You are currently pregnant or breastfeeding.
You have long-term liver or kidney problems that affect how these organs work.
You have a serious blood-related cancer or blood disorder.
You currently have an active hepatitis infection (a liver infection caused by a hepatitis virus).
You have had an active infection of any kind in the four weeks before joining the trial.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 27 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Sohag University

Registry

ClinicalTrials.gov

Start date

5 August 2025

Est. completion

1 June 2026

Where this trial is recruiting

🇪🇬 Egypt

Primary endpoints

assess the utility of the albumin-to-globulin ratio (AGR) as reliable, non-invasive biomarker for predicting disease activity in patients with systemic lupus erythematosus (SLE).

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov